What happens when an oncologist and a mortician discuss the mystery of death? Dr. Manish Agrawal joins the Death And podcast to bridge the gap between clinical rigor and human mystery. From the “collusion of denial” to the “infinity” found between birth and death, discover how psychedelic-assisted care invites patients back into their own experience to find peace and connection.
Dr. Manish Agrawal, CEO of Sunstone Therapies, joined Great Day Washington to discuss adjustment disorder—a common but frequently overlooked emotional response to serious illnesses like cancer, MS, and Parkinson’s. While modern medicine excels at treating physical symptoms, Dr. Agrawal highlights the “collusion of denial” that often leaves patients to navigate emotional upheaval in silence. Learn how Sunstone is addressing this critical gap through the REKINDLE Phase 2 study, an innovative clinical trial evaluating an investigational treatment for psychological distress in patients facing life-altering diagnoses.
Why veterans’ trauma requires new therapeutic approaches.
National Geographic recently highlighted emerging research on psilocybin-assisted therapy for patients facing advanced cancer and end-of-life distress. The article explores how psychedelic-assisted therapy may help reduce depression, anxiety, and existential suffering when delivered within structured clinical settings.
Sunstone Therapies is working to set the industry standard for high quality training that prepares mental health professionals to work safely, ethically, and effectively in psychedelic therapy research.
Researchers from Sunstone Therapies, Dana-Farber Cancer Institute, Harvard Medical School, and the University of Vermont have published new findings that deepen understanding of how psilocybin-assisted group therapy can help people with cancer and depression navigate profound existential challenges.
Fall 2025 At Sunstone Therapies, healing is understood as a journey—one that unfolds with time, trust, and compassionate care. Known […]
Blending Science, Story, and the Human Side of Healing October, 2025 — Sunstone Therapies CEO Dr. Manish Agrawal joined Dan […]
At Sunstone Therapies, we believe healing goes deeper than the surface. While traditional oncology focuses on physical treatments, many patients still struggle with the psychological and emotional challenges of cancer. Our mission is to address the whole patient, which is why we created the 2Dose Study. This clinical trial, led by Dr. Manish Agrawal, builds on our initial study where 80% of participants experienced a greater than 50% reduction in depressive symptoms. The 2Dose Study will explore whether psilocybin is more effective than an active placebo and if two doses are better than one. The trial is open to people with all stages of cancer, not just advanced disease.